Therapy in IgA nephropathy--when and how to do it |
| |
Authors: | Vas Tibor Kovács Tibor Késoi István Sági Balázs Degrell Péter Wittmann István Nagy Judit |
| |
Institution: | Pécsi Tudományegyetem, Klinikai K?zpont II. Belgyógyászati Klinika és Nefrológiai Centrum Pécs Pacsirta. |
| |
Abstract: | IgA nephropathy is the most common primary glomerulonephritis worldwide. The clinical spectrum covers a wide range of features from minor urinary abnormalities (asymptomatic hematuria and mild proteinuria with normal renal function) to acute and chronic renal insufficiency. Ideally, the goal of treatment would be to correct any defects in IgA1 glycosylation and to modify mesangial deposition or removal of IgA1 deposits. There are only a few randomized controlled trials in IgA nephropathy; for this reason most treatment options are largely based on expert opinion. Authors discuss therapeutic options of different clinical pictures and the optimized renoprotective treatment of all IgA nephropathy patients. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |